Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.

Volume 3 (2007), Issue 9 (September)

1. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
   Int J Drug Policy. [Abstract] [Full-text]
2. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
   Ophthalmology, 114(9): 1599-606. [Abstract] [Full-text]
3. Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills.
   Curr Med Res Opin, 23(9): 2193-203. [Abstract] [Full-text]
4. Effects of an integrated clinical information system on medication safety in a multi-hospital setting.
   Am J Health Syst Pharm, 64(18): 1969-77. [Abstract] [Full-text]
5. Effect of dilution with beverages on the smell and taste of oral acetylcysteine.
   Am J Health Syst Pharm, 64(18): 1965-8. [Abstract] [Full-text]
6. Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.
   Am J Health Syst Pharm, 64(18): 1943-9. [Abstract] [Full-text]
7. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients.
   Am J Health Syst Pharm, 64(18): 1935-42. [Abstract] [Full-text]
8. Chronic disease and disasters medication demands of hurricane katrina evacuees.
   Am J Prev Med, 33(3): 207-10. [Abstract] [Full-text]
9. An innovative approach to integrated medicines management.
   J Eval Clin Pract, 13(5): 781-8. [Abstract] [Full-text]
10. Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001-2005.
    Osteoporos Int, 18(10): 1429-33. [Abstract] [Full-text]
11. Comparison of hospital pharmacy practice in France and Canada: can different practice perspectives complement each other?
    Pharm World Sci, 29(5): 526-33. [Abstract] [Full-text]
12. A survey of Estonian consumer expectations from the pharmacy service and a comparison with the opinions of pharmacists.
    Pharm World Sci, 29(5): 546-50. [Abstract] [Full-text]
13. The variability and quality of medication container labels.
    Arch Intern Med, 167(16): 1760-5. [Abstract] [Full-text]
14. Assessing core manipulative skills in a large, first-year laboratory.
    Adv Physiol Educ, 31(3): 266-9. [Abstract] [Full-text]
15. Pharmacy benefit caps and the chronically ill.
    Health Aff (Millwood), 26(5): 1333-44. [Abstract] [Full-text]
16. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care.
    J Am Pharm Assoc (2003), 47(5): 620-8. [Abstract] [Full-text]
17. Designing pharmacy services based on grocery store patron preferences.
    J Am Pharm Assoc (2003), 47(5): 605-12. [Abstract] [Full-text]
18. Effect of strategic planning education on attitudes and perceptions of independent community pharmacy owners/managers.
    J Am Pharm Assoc (2003), 47(5): 599-604. [Abstract] [Full-text]
19. Constructs underlying community pharmacy dispensing functions relative to Florida pharmacy technicians.
    J Am Pharm Assoc (2003), 47(5): 588-98. [Abstract] [Full-text]
20. How does a Belgian health care provider deal with a request for emergency contraception?
    Eur J Contracept Reprod Health Care. [Abstract] [Full-text]
21. The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees.
    Health Serv Res, 42(5): 1926-42. [Abstract] [Full-text]
22. Improving practice the Hospital Pharmacy Initiative revisited.
    J Antimicrob Chemother, 60(4): 709-11. [Abstract] [Full-text]
23. Impact of pharmacy validation in a computerized physician order entry context.
    Int J Qual Health Care, 19(5): 317-25. [Abstract] [Full-text]
24. Improving practice working together to improve the use of antimicrobials.
    J Antimicrob Chemother, 60(4): 712-4. [Abstract] [Full-text]
25. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Int J Drug Policy, 18(5): 417-25. [Abstract] [Full-text]
26. The risk of traffic accidents after prescriptions of carisoprodol.
    Accid Anal Prev, 39(5): 1050-5. [Abstract] [Full-text]
27. Influence of Pharmaceutical Care intervention and communication skills on the improvement of pharmacotherapeutic outcomes with elderly Brazilian outpatients.
    Patient Educ Couns, 68(2): 186-92. [Abstract] [Full-text]
28. A Prospective Study of Adherence and Virologic Failure in HIV-Infected Patients: Role of a Single Determination of Plasma Levels of Antiretroviral Medications.
    J Int Assoc Physicians AIDS Care (Chic Ill). [Abstract] [Full-text]
29. Community pharmacy and public health in Great Britain, 1936 to 2006: how a phoenix rose from the ashes.
    J Epidemiol Community Health, 61(10): 844-8. [Abstract] [Full-text]
30. Adverse Drug Events in Pediatric Outpatients.
    Ambul Pediatr, 7(5): 383-389. [Abstract] [Full-text]
31. The management of severe toxic alcohol ingestions at a tertiary care center after the introduction of fomepizole.
    Am J Emerg Med, 25(7): 799-803. [Abstract] [Full-text]
32. Interval to treatment of sexually transmitted infections in adolescent females.
    J Pediatr Adolesc Gynecol, 20(5): 275-9. [Abstract] [Full-text]
33. Pharmacy access to emergency contraception in rural and frontier communities.
    J Rural Health, 23(4): 294-8. [Abstract] [Full-text]
34. The experience of rural independent pharmacies with medicare part D: reports from the field.
    J Rural Health, 23(4): 286-93. [Abstract] [Full-text]
35. Healthy Young Adults: description and use of an innovative health insurance program.
    J Adolesc Health, 41(4): 350-6. [Abstract] [Full-text]
36. Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre.
    J Clin Pharm Ther, 32(5): 449-55. [Abstract] [Full-text]
37. Emergency department drug orders: does drug storage location make a difference?
    Ann Emerg Med, 50(4): 414-8. [Abstract] [Full-text]
38. Self-treatment of opioid withdrawal with a dietary supplement, kratom.
    Am J Addict, 16(5): 352-6. [Abstract] [Full-text]
39. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.
    Ann Pharmacother, 41(10): 1569-82. [Abstract] [Full-text]
40. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Am J Cardiol, 100(7): 1061-7. [Abstract] [Full-text]
41. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
    Pain Med, 8(7): 573-84. [Abstract] [Full-text]
42. Antidepressants in children and adolescents--changes in utilisation after safety warnings.
    Pharmacoepidemiol Drug Saf, 16(9): 1048-53. [Abstract] [Full-text]
43. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Pharmacoepidemiol Drug Saf, 16(9): 999-1005. [Abstract] [Full-text]
44. Effect of drug combinations on admission for recurrent myocardial infarction.
    Heart, 93(10): 1226-30. [Abstract] [Full-text]
45. A gap analysis approach to assess patient persistence with glaucoma medication.
    Am J Ophthalmol, 144(4): 520-4. [Abstract] [Full-text]
46. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration.
    Cornea, 26(9): 1087-9. [Abstract] [Full-text]
47. Implementation of inpatient and outpatient tobacco-cessation programs.
    Am J Health Syst Pharm, 64(19): 2074-9. [Abstract] [Full-text]
48. Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations.
    Am J Health Syst Pharm, 64(19): 2069-73. [Abstract] [Full-text]
49. Effect of pharmacy practice residency training on residents' knowledge of and interest in clinical research.
    Am J Health Syst Pharm, 64(19): 2055-63. [Abstract] [Full-text]
50. Pharmacist recognition of and adherence to medication-use policies and safety practices.
    Am J Health Syst Pharm, 64(19): 2050-4. [Abstract] [Full-text]
51. Observations on the use of ready-to-use and point-of-care activated parenteral products in automated dispensing cabinets in U.S. hospitals.
    Am J Health Syst Pharm, 64(19): 2037-43. [Abstract] [Full-text]
52. Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data.
    Clin Experiment Ophthalmol, 35(7): 602-11. [Abstract] [Full-text]
53. The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry.
    Acad Med, 82(10): S1-3. [Abstract] [Full-text]
54. A survey of propofol abuse in academic anesthesia programs.
    Anesth Analg, 105(4): 1066-71, table of contents. [Abstract] [Full-text]
55. Discrepancies in medication entries between anesthetic and pharmacy records using electronic databases.
    Anesth Analg, 105(4): 1061-5, table of contents. [Abstract] [Full-text]
56. Development of a scheduled drug diversion surveillance system based on an analysis of atypical drug transactions.
    Anesth Analg, 105(4): 1053-60, table of contents. [Abstract] [Full-text]
57. Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension.
    BMC Ophthalmol, 7(1): 16. [Abstract] [Full-text]

© 2005-2008 Pharmacy Research Today. All Rights Reserved.